Aspire Biopharma Holdings, Inc. ASBP 深 滬
已收盤 02-06 16:00:00 美东时间
1.46
+0.140
+10.61%
華盛通- 最 高1.49
- 今 開1.35
- 成交量 20.69万股
- 最 低 1.26
- 昨 收 1.32
- 總市值 505.33万
- 52周最高 10.50
- 市盈率 靜 --
- 換手率 5.98%
- 52周最低 0.0462
- 委 比 -99.50%
- 總股本 346.12万
- 歷史最高 15.80
- 量 比 0.15
- 振 幅 17.42%
- 歷史最低 0.0462
- 每 手 1
- 風險率 2.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Monday's Intraday Session
Gainers AstraZeneca PLC Ordinary Shares (NYSE:AZN) stock rose 107.1% to $192.1...
02-03 01:05
Aspire Biopharma Files Patent For Sublingual Powder Formulation Of Clopidogrel And Methods Of Use Thereof
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.Clopidogrel, currently sold under the brand name Plavix®, was the 41st most
01-27 21:02
Aspire Biopharma Holdings shares are trading lower after the company announced a 1-for-40 reverse stock split.
Aspire Biopharma Holdings shares are trading lower after the company announced ...
01-14 22:21
Aspire Biopharma shares are trading higher after the company announced FDA feedback from a pre-IND meeting supporting a 505(b)(2) filing for high-dose sublingual aspirin without requiring additional studies beyond its planned trial.
Aspire Biopharma shares are trading higher after the company announced FDA feed...
01-07 21:06
Aspire Biopharma Granted Nasdaq Extension, Moves From The Nasdaq Global Select Market To The Nasdaq Capital Market On December 15, 2025
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, received notice (the "Notice") on December 11, 2025, from the Nasdaq
2025-12-13 06:06
Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Gorilla Technology Group Inc. (NASDAQ:GRRR) rose sharply in pre-marke...
2025-11-18 19:10
Aspire Biopharma Hldgs Q3 EPS $(0.04) Down From $(0.01) YoY, Sales $1.941K
Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $1.941 thousand
2025-11-14 22:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
2025-11-11 20:07
Aspire Biopharma Showcases Sublingual High-Dose Aspirin At CPHI Frankfurt
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the CPHI Frankfurt trade
2025-11-06 22:12
Aspire Biopharma Faces Nasdaq Delisting Notice
An update from Aspire Biopharma Holdings ( ($ASBP) ) is now available. Aspire B...
2025-10-18 05:51
